Sweet's syndrome induced by removable partial denture using a CoCr alloy: case report.

Oral Surgery, Department of Stomatological Science, G. Messina University of Palermo, Palermo, Italy.
Minerva stomatologica 05/2010; 59(5):285-7, 288-9.
Source: PubMed


Sweet's syndrome is an acute febrile neutrophilic dermatosis characterized by fever, neutrophilia and erythematous skin lesions. This disease typically occurs as a reactive event in response to infective, inflammatory or neoplastic processes. The aim of this work was to describe a rare case of Sweet's syndrome induced by dental removable partial denture using a CoCr alloy.

4 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To highlight the recent observations regarding not only research but also the clinical features and management of Sweet's syndrome. Some of the new insights concerning Sweet's syndrome include: (1) bortezomib-induced Sweet's syndrome (some of which are the histiocytoid variant), (2) a rare extracutaneous manifestation of Sweet's syndrome with cardiovascular involvement including coronary artery occlusion, and (3) the possibility that photosensitivity may have a role in the pathogenesis of Sweet's syndrome. Animal models of Sweet's syndrome and new associated medication have been observed. The definitive mechanism of pathogenesis still remains to be elucidated. Recent observations in paediatric patients suggest evaluation of dermatosis-related cardiac involvement in patients with post-Sweet's syndrome cutis laxa. Treatment advances include antitumour necrosis factor- alpha drugs; however, these medications have also been associated with inducing Sweet's syndrome. Nearly 50 years after the initial description of an acute febrile neutrophilic dermatosis by Dr Robert Douglas Sweet, the dermatosis remains a fascinating condition with regard to laboratory investigation, clinical manifestations and treatment.
    Current opinion in hematology 01/2013; 20(1):26-35. DOI:10.1097/MOH.0b013e32835ad132 · 3.97 Impact Factor

  • La Revue de Médecine Interne 03/2013; 34(3):181–183. DOI:10.1016/j.revmed.2012.07.004 · 1.07 Impact Factor